Your privacy choices

Essential storage keeps the site working. With your permission, we also measure visits and interactions on public research pages using first-party analytics. Optional third-party analytics and advertising trackers are currently disabled.

Read our privacy policy
Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.

Hinge Health, Inc.

HNGENYSE
Wall Street Score · overall investment41/100
$97.67USD$-0.27 (-0.28%)
Company website www.hingehealth.com
Headquarters455 Market Street, San Francisco, CA, 94105, US
Financial statement currencyUSD · no FX conversion applied
Healthcare · Medical - Healthcare Information Services
Price updated todayFinancials updated Oct 1, 2026
Price Chart+$6.91 (+7.61%)
2026-09-042026-09-092026-09-112026-09-152026-09-172026-09-212026-09-232026-09-252026-09-292026-10-02$87.00$90.00$93.00$96.00$99.00

Company & revenue

About Hinge Health, Inc.

Who they are

Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.

Detailed revenue, brand and relationship research has not yet been completed for HNGE.

Wall Street Score

Overall investment score · Quality, value, risk and opportunity

41

Weak

PoorElite

View category scores →

Company Quality

How good is the actual business—regardless of today’s stock price?

75

Strong

Financial Strength

68

Business Quality / Moat

79

Management

80

Growth Quality

75

Great Company · Expensive Stock

Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.

Opportunity

Opportunity Score · How does the current price compare with estimated value?

36

Avoid

Based on current valuation, company quality, recent trends, and available market signals.

View score details →

Model Outlook

12-month model · What does the model think happens next?

46/100

Building Historical Record

Model Score 46/100 — estimates relative performance potential, distinct from WallStreetScore (company quality).

Probability unavailable — the model has not produced a calibrated probability yet.

Click for full breakdown →

WSS View

The quick read

WSS currently sees meaningful weaknesses in the company-strength profile.

At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.

The model outlook is currently cautious.

What we like
  • •Balance-sheet / debt profile scores strongly
  • •Recent buyback activity is present
What to watch
  • •Valuation is a weaker part of the current profile
  • •Revenue fundamentals are weak
  • •Asset quality is a weaker factor

Company-specific research

Questions worth answering for HNGE

Research inputs 100% complete

These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.

  • •Can HNGE maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
  • •Is HNGE's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
  • •How is HNGE likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
  • •What future growth or profitability would be needed to justify HNGE's current valuation?
Business analysis: 36 days ago · Fresh

Essential Investment Snapshot

Wall Street Score

41

0–100 · Weak

Opportunity Score

36

0–100 · Weak

Market Cap

$7.56B

P/E Ratio

72.2

EPS

$1.35

52-Week High

$98.41

52-Week Low

$30.08

Beta

1.36

Intrinsic Value

$51.84

Analyst Target

$105.00

Shares Outstanding

81.7M

Total Revenue

$720.1M

Total Debt

$5.9M

Dividend

No current dividend

View dividend history

Liquidation Value / Share

$4.21

Estimated net asset value per share

Momentum & Volatility Signals

Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.

0–100 market signals
Momentum
69/ 100
+5 pts / 5d

Building upward momentum

5D +2.2% · 20D +7.6% · RSI 57 · Price vs 20D avg +4.3%
Volatility
30/ 100
-12 pts / 5d

Low movement

20D realized vol 38.9% · 60D 46.5% · Acceleration 0.84x
Momentum = Where is it going?

A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.

Volatility = How violently is it moving?

A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.

Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.

Notices for HNGE

Detected from reported data — verify before acting.

Historical repurchase activity

Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.

Community Sentiment

0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)

No personal call yet on HNGE.

What the Bulls Say

  • +Product opportunity: Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.
  • +Positive free cash flow may provide capacity to invest in growth.

What the Bears Say

No strong bearish data point is currently available.

Bull and bear cases summarize disclosed catalysts, growth opportunities and risks; they are not buy or sell recommendations.

Create a free account to make a call.

Scores

Click any score for full breakdown
Wall Street Score
Weak41/ 100
Weak (0–50)Fair (51–71)Strong (72+)

Weak

41

Tap for breakdown →

Strong

83

Debt Cost—
Debt Reduction YoY27.4%
Debt / Equity0.02x

Tap for breakdown →

Weak

46

Revenue YoY22.5%
Revenue CAGR41.7%
Net Margin15.1%

Tap for breakdown →

Poor

35

Asset Growth YoY10.6%
Liquidation/Share$4.21
Net Assets/MCap0.11x

Tap for breakdown →

Poor

8

Earnings Yield1.4%
Buyback Yield0.3%
Debt Cost—

Tap for breakdown →

Strong

80

ROIC-8.5%
ROE31.7%
ROA13.2%

Tap for breakdown →

Strong

79

EPS Growth—
FCF/Share Growth2.6%
Rev/Share Growth43.8%

Tap for breakdown →

Poor

0

Intrinsic Value$51.84
Value Reference$31.11
MOS-0.9%

Tap for breakdown →

Fair

59

Revenue46
Moat79
Valuation0

Tap for breakdown →

Poor

0

MOS %-0.9%
Value Reference$31.11
Deep Discount Reference$20.74

Tap for breakdown →

Fair

50

Interest Coverage—
ROIC-8.5%
FCF Yield2.3%

Tap for breakdown →

Poor

34

Financial50
Valuation0
Debt83

Tap for breakdown →

Fair

53

Survival Years0.4 yrs
Current Ratio1.47x
FCF Margin0.3%

Tap for breakdown →

Was this stock page easy to understand?

One click helps us improve the research experience. This is not tied to an investment decision.

Score Changes

4 historical score records available

Previous Score

41

Sep 28, 2026

Change

-0.1

points

Current Score

41

Oct 1, 2026

Category Changes

Revenue-0.1
Debt0
Assets-0.2
Capital0
Management0
Moat0
Valuation0
Buffett0

HNGE decreased 0.1 points because some fundamentals weakened.

Projected Score

Projected Score

46

Projected Change

+5.2%

Preliminary comparable-period financial changes suggest improvement of approximately 5.2 points. This is a projected estimate, not the official WallStreetScore.

Price vs. Value

Overvalued

Current Price

$97.67

Intrinsic Value

$51.84

Difference

+$45.83

+88.4% vs IV

Margin of Safety

-88.4%

UndervaluedFair ValueOvervalued
Value Reference: $31.11
Deep Discount Reference: $20.74

Related Companies

Medical - Healthcare Information Services

DOCS

Doximity, Inc.

55Fair
$27.93View

HQY

HealthEquity, Inc.

48Weak
$88.46View

OPRX

OptimizeRx Corp.

42Weak
$8.57View

OMDA

Omada Health

42Weak
$20.37View

PRVA

Privia Health Group, Inc.

41Weak
$20.30View

CCLD

CareCloud, Inc.

41Weak
$2.02View

News

MarketBeat4d ago

3 Healthcare Stocks Showing Why the Sector Still Has Momentum

Defense World9d ago

Hinge Health (NYSE:HNGE) President James Pursley Sells 33,000 Shares of Stock

Defense World11d ago

Critical Comparison: Hinge Health (NYSE:HNGE) & CorVel (NASDAQ:CRVL)

Zacks Investment Research11d ago

Reasons to Hold Hinge Health Stock in Your Portfolio for Now

Related Stock Research

Continue researching this company with related Wall Street Score rankings and investing guides.

Highest Wall Street Score stocksBest growth stocksBest healthcare stocksHow Wall Street Score worksHow to analyze a stockUnderstanding financial healthIntrinsic value guide

Score Alerts

Premium unlocks alerts when a score rises, falls, or reaches your target price.

Start 7-Day Free Trial

Portfolio Score

Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.

Start 7-Day Free Trial